News
FDA rushed out agency-wide AI tool—it’s not going well
FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't connected to the Internet or the FDA's internal system, and has problems uploading documents and allowing users to submit questions.
Tonight’s the premiere of Dimension 20’s steampunk-themed Cloudward, Ho! series. I’m excited; anyone else? (If you’re ...
The FDA launched an artificial intelligence tool Monday dubbed Elsa, with Commissioner Marty Makary hyping the effort’s early ...
AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...
A new FDA artificial intelligence tool designed to streamline medical device reviews is faltering in its early rollout stages, raising concerns for agency staff and ethics experts about its ...
Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help ...
The FDA launched Elsa, its first generative AI tool, to streamline reviews and modernize agency workflow across all centers.
The FDA rolled out a generative AI tool for speeding regulatory reviews, announcing its launch nearly a month ahead of a June ...
The FDA is moving quickly to bring artificial intelligence (AI) into the heart of its regulatory review process. On May 8, ...
Jeremy Walsh previously led enterprise-scale technology deployments across federal health and intelligence agencies; FDA has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback